RxDoctor Payments Data

Darel Barnett, MD

Pain Medicine · Louisville, KYNPI 1285776526

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.9% of the total across 345 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 26.7% of the total. Reporting peaked in 2024 at $3,156 and has fallen 71.7% since, to $894 in 2025.

$8,895in general payments, 2019–2025

Across 345 payments — averaging $25.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$2K
  • Abbott$2K
  • Boston Scientific$1K
  • AbbVie$814
  • Medtronic$641
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$589
  • plus $2K from 31 others

What the payments were for

  • Travel & lodging$7238%
  • Food & beverage$8,17392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,895 in reported general payments places this provider in the 70th percentile of 90 pain medicine providers in Kentucky.

See all pain medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$214,321
Medicare patients
512
Services billed
2,993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl22$38,329
Nucynta ErTapentadol Hcl12$21,840
Xtampza ErOxycodone Myristate22$20,266
NucyntaTapentadol Hcl16$20,141
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen496$12,620
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen417$7,882
Fentanyl44$5,428
Lidocaine30$4,240
Morphine Sulfate ErMorphine Sulfate157$3,847
Oxycodone Hcl115$2,481
Pregabalin38$1,859
Gabapentin82$1,856
Morphine Sulfate25$1,144
Methadone Hcl48$663
Hydromorphone Hcl25$410

Paid to pharmacies, not to this prescriber.

Other pain medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →